Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Study to Evaluate the Safety and Efficacy of Minocycline Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

ClinicalTrials.gov ID: NCT03888378

Public ClinicalTrials.gov record NCT03888378. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 2:39 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Double-Masked, Randomized, Vehicle-Controlled Study of the Efficacy and Safety of HY02 Ointment in Subjects With Inflamed Meibomian Gland Dysfunction

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To evaluate the efficacy and safety of two strengths of HY02 Ointment versus Vehicle administered twice daily for twelve weeks in subjects with a diagnosis of Inflamed Meibomian Gland Dysfunction.

Study identification

NCT ID
NCT03888378
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Hovione Scientia Limited
Industry
Enrollment
270 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 2, 2019 (Actual)
Primary completion
Sep 18, 2020 (Actual)
Completion
Feb 1, 2021 (Actual)
Last update posted
Mar 5, 2021

2019 – 2021

United States locations

U.S. sites
20
U.S. states
10
U.S. cities
19
Facility City State ZIP Site status
Clinical site - 4 Azusa California 91702 —
Clinical site - 16 Huntington Beach California 92647 —
Clinical site - 12 Inglewood California 90301 —
Clinical site - 13 Mission Hills California 91345 —
Clinical site 10 Rancho Cordova California 95670 —
Clinical site - 15 Jacksonville Florida 32256 —
Clinical Site - 18 Largo Florida 33773 —
Clinical site - 6 Indianapolis Indiana 46260 —
Clinical site - 20 New Albany Indiana 47150 —
Clinical site - 19 Kansas City Missouri 64111 —
Clinical site - 3 St Louis Missouri 63131 —
Clinical site - 9 St Louis Missouri 63131 —
Clinical site - 7 Las Vegas Nevada 89145 —
Clinical site - 5 Asheville North Carolina 28803 —
Clinical site - 11 Mason Ohio 45040 —
Clinical site - 2 Memphis Tennessee 38119 —
Clinical site - 14 Cedar Park Texas 78613 —
Clinical Site - 1 El Paso Texas 79902 —
Clinical site - 8 League City Texas 77573 —
Clinical site - 17 Norfolk Virginia 23502 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03888378, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 5, 2021 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03888378 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →